Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fenghuan Sun

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Annals of Translational Medicine|May 14, 2021
Neoadjuvant immunotherapy combined with chemotherapy for local advanced non-small cell lung cancer: a case reportJie Yang, Haoran Xia, Fenghuan Sun, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|February 6, 2025
Segmentectomy for non-peripheral and peripheral small-sized non-small-cell lung cancerZhen Yang, Jie Dai, Yao Wang, et al.
International Journal of Clinical and Health Psychology : IJCHP|February 21, 2025
Longitudinal relationship between posttraumatic growth and distress in lung cancer patients during neoadjuvant immunotherapyQiao Chu, Fenghuan Sun, Xinsheng Zhu, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 13, 2020
Outcomes of sleeve lobectomy versus pneumonectomy: A propensity score-matched studyJian Chen, Konstantinos Marios Soultanis, Fenghuan Sun, et al.
The Annals of Thoracic Surgery|February 3, 2024
Pulmonary Function Recovery and Displacement Patterns After Anatomic Segmentectomy vs LobectomyJie Dai, Fenghuan Sun, Minwei Bao, et al.
The Annals of Thoracic Surgery|February 17, 2022
Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung CancerPeng Zhang, Jie Dai, Fenghuan Sun, et al.
Genome Biology|June 26, 2020
Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancerJian Chen, Yun Tan, Fenghuan Sun, et al.
BMC Medicine|July 18, 2025
Neoadjuvant camrelizumab plus chemotherapy or apatinib for resectable stage IIA-IIIA NSCLC: a multicenter, two-arm, phase II exploratory trialShuyu Ji, Zhenxin Sheng, Dongliang Bian, et al.
Genome Medicine|March 3, 2023
Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencingJunjie Hu, Lele Zhang, Haoran Xia, et al.
Nature Communications|August 3, 2023
Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II studyDongliang Bian, Liangdong Sun, Junjie Hu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Annals of Translational Medicine|May 14, 2021
Neoadjuvant immunotherapy combined with chemotherapy for local advanced non-small cell lung cancer: a case reportJie Yang, Haoran Xia, Fenghuan Sun, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|February 6, 2025
Segmentectomy for non-peripheral and peripheral small-sized non-small-cell lung cancerZhen Yang, Jie Dai, Yao Wang, et al.
International Journal of Clinical and Health Psychology : IJCHP|February 21, 2025
Longitudinal relationship between posttraumatic growth and distress in lung cancer patients during neoadjuvant immunotherapyQiao Chu, Fenghuan Sun, Xinsheng Zhu, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 13, 2020
Outcomes of sleeve lobectomy versus pneumonectomy: A propensity score-matched studyJian Chen, Konstantinos Marios Soultanis, Fenghuan Sun, et al.
The Annals of Thoracic Surgery|February 3, 2024
Pulmonary Function Recovery and Displacement Patterns After Anatomic Segmentectomy vs LobectomyJie Dai, Fenghuan Sun, Minwei Bao, et al.
The Annals of Thoracic Surgery|February 17, 2022
Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung CancerPeng Zhang, Jie Dai, Fenghuan Sun, et al.
Genome Biology|June 26, 2020
Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancerJian Chen, Yun Tan, Fenghuan Sun, et al.
BMC Medicine|July 18, 2025
Neoadjuvant camrelizumab plus chemotherapy or apatinib for resectable stage IIA-IIIA NSCLC: a multicenter, two-arm, phase II exploratory trialShuyu Ji, Zhenxin Sheng, Dongliang Bian, et al.
Genome Medicine|March 3, 2023
Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencingJunjie Hu, Lele Zhang, Haoran Xia, et al.
Nature Communications|August 3, 2023
Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II studyDongliang Bian, Liangdong Sun, Junjie Hu, et al.
Pageof 2